BMC Clinical Pharmacology

unofficial impact factor 1.36

Open Access Correspondence

Does atenolol differ from other β-adrenergic blockers?

Ivar Aursnes*, Jan-Bjørn Osnes, Ingunn F Tvete, Jørund Gåsemyr and Bent Natvig

BMC Clinical Pharmacology 2007, 7:4 doi:10.1186/1472-6904-7-4

Accesses  

  • Last 30 days: 95 accesses
  • Last 365 days: 914 accesses
  • All time: 7231 accesses